Solid Phase Extraction Market Estimated to Witness a Vigorous Growth by 2023

 Solid Phase Extraction Market Analysis

As per Market Research Future (MRFR) analysis, the global solid phase extraction market is expected to reach USD 474.73 million with a CAGR of 4.62% from 2017 to 2023 (forecast period). The report on global solid phase extraction offers the in-depth primary research and a thorough analysis of qualitative and quantitative aspects by various industry analysts and key opinion leaders in order to provide valuable insight into market demand and industry performance.

Solid phase extraction (SPE) is a commonly used sample preparation process for purifying drugs from biological fluids prior to high-performance liquid chromatography. SPE is usually performed manually. In some instances, cost-effectiveness and disposability make manually operated SPE cartridges, disks, and plates preferable to automated systems.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7552

In recent years, technological developments in instrumentation, government investment in academics and life sciences, and expansion in the generic pharmaceutical industry and contract research organizations (CROs) have contributed to the development of the global demand for solid phase extraction industries. 

Solid Phase Extraction Market Dynamics

Solid phase extraction (SPE) is a sample preparation process by which compounds dissolved or suspended in a liquid mixture are isolated from other compounds in the mixture as per their physical and chemical properties. Growth in generics and CROs due to rising demand for drug production has contributed to a rise in the market for the solid phase extraction industry.

Government investments have increased over the last few years in the academic and life science sectors, which are the critical source of revenue for the solid phase extraction instrument manufacturers, and have also contributed to the development of the overall market.

However, the rising cost of instruments and government policies and regulations is likely to hinder market growth over the forecast period.

Solid Phase Extraction Market Segmentation

The global solid phase extraction market has been segmented into type and application.

Based on type, the global market for solid phase extraction has been divided into SPE disk and SPE cartridge. The segment for SPE cartridge is likely to register the highest CAGR of around 5.17% during the forecast period.

Based on application, the global market for solid phase extraction market is segmented into hospitals and clinics, pharmaceutical industries, and environmental care. 

Solid Phase Extraction Market Regional Analysis

Region-wise, the global solid phase extraction market is divided into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas are expected to dominate the market for the global solid phase extractive industry. It is due to the growing use of solid phase extraction in various industries, such as pharmaceuticals, biotechnology, agriculture, and others. The Americas is forecast to hold a 39.9% share in the global market for the solid phase extraction industry

Europe has shown considerable market growth as a result of the increase in biomedical and medical research in Europe.

The Asia Pacific is estimated to be the fastest-growing region on the market. The latest developments in instrumentation, changing economic conditions, growing innovation in biotechnology, and pharmaceutical research organizations in developing countries in the Asia Pacific are factors driving the growth of the global demand for solid phase extraction.

The Middle East and Africa has the lowest market share due to their low disposable income.

Solid Phase Extraction Market Key Players

The prominent participants in the global solid phase extraction industry market are Thermo Fisher Scientific Inc, PerkinElmer Inc, Gerstel GmbH & Co. KG, 3M, Gilson Incorporated, Merck KGaA, Agilent Technologies Inc., Biotage AB, Waters Corporation, GL Sciences Inc, and Tecan Trading AG.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/solid-phase-extraction-market-7552

Neonatal Intensive Care Market to Witness Widespread Expansion During 2020 to 2023

 

Market Highlights

It is estimated that the global neonatal intensive care market is expected to register a CAGR ~5.5% during the forecast period of 2018–2023 with an estimated market value of 9.1 billion in 2017.

The global market is driven by factors such as rising prevalence of diseases in new-born children and increasing neonatal population. According to data published by the Centers for Disease Control and Prevention in January 2017, there were 3,945,875 births in the US in 2017.

On the other hand, the lack of awareness, high cost of equipment, and lack of skilled professionals is restraining the growth of neonatal intensive care market. For instance, according to a report published by the International Journal of Neonatal Screening in September 2018, the reports of false positive cases in neonates are increasing for various diseases.

Browse Sample of the Report @   https://www.marketresearchfuture.com/sample_request/7513 

The global neonatal intensive care market is currently dominated by many market players. The key players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, PerkinElmer’s QSight 210 MD system launched in September 2016, utilizes tandem quadrupole analysis which provides regular robust screening along with higher sensitivity and faster scanning.

Regional Analysis

The market in the Americas is expected to dominate the global Neonatal Intensive Care market during the forecast period. The rising prevalence of congenital disorders in new-born, increasing neonatal population and government support are driving the growth of the market in the Americas. According to a data published by the Centers for Disease Control and Prevention (CDC) in November 2018, congenital heart defects (CHDs) affect approximately 1% or about 40,000 births per year in the US.

Europe showed a considerable amount of growth in the global neonatal intensive care market. The market growth in this region is because of the presence of a well-established healthcare system and increase in insurance coverage for pets. Also, technological advancements in the industry and government support in terms of National Health Service and health insurance are expected to drive the market growth.

Asia-Pacific is estimated to be the fastest growing region in the market due to increased pet adoptions and rise in the number of animal welfare programs.

On the other hand, the Middle East & Africa has the least share of the market due to the low disposable income. According to the American Society of Hematology (ASH), it led a campaign to fight sickle cell disease in Africa in June 2018. It also urged the governments, particularly in sub-Saharan Africa, to invest in new-born intensive care units for the betterment of the neonates.

Segmentation

The global neonatal intensive care market has been segmented into product, and end user. The market, based on product, has been segmented into infant warmers, incubators, respiratory devices, neonatal monitoring devices, convertible warmer & incubators, phototherapy equipment, catheters, and others. The market, by infant warmers, has been segmented into electric infant warmers, and non-electric infant warmers. The market, by neonatal monitoring devices, has been sub-segmented into cardiopulmonary monitor, blood pressure monitor, pulse oximeters, capnographs, and others. The market, by end user, has been segmented into hospitals, childcare clinics, and others.

Key Players

Some of the key players in the global neonatal intensive care market are B. Braun Melsungen AG, DRE Medical, Digicare Biomedical Technology Inc., Henry Schein, Jorgensen Labs, Medtronic, Midmark Corporation, Patterson Companies, Inc., Smiths Group plc, and Vetland Medical Sales & Services.

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/neonatal-intensive-care-market-7513

Medical Carts Market Poised to Witness a Significant Growth by 2023

 Medical Carts Market Analysis  

The medical carts market was worth USD 1,100 million in 2017 and is likely to grow at a 12.1% CAGR between 2017- 2023, according to the recent report by Market Research Future (MRFR). A medical cart or a medical trolley, simply put, is a wheeled cabinet having trays and drawers which are used in different therapeutic, surgical, and medical modalities. Medical carts are extensively used across clinical settings and hospitals for keeping drugs, medical devices, equipment, and tools for specified treatments. Wall-mounted workstations, medical computing carts, mobile computing carts, medication carts, & others are the different types of medical carts. It is available in different materials such as plastic, metal, and others. Owing to its various benefits and alluring features, medical carts are widely used in hospitals and clinics, ambulatory surgical centre, and others.  

Get a FREE Sample (Including COVID19 Impact Analysis, Full TOC, Tables and Figures) of Medical Carts Market @ https://www.marketresearchfuture.com/sample_request/7436 

Various factors are adding to the global medical carts market growth. These factors, as per the latest MRFR report, comprise increasing use of medical carts at home, easy availability of advanced medical cart through e-commerce & retail stores, technological advances in medical devices, and rising cases of musculoskeletal injury.  

On the contrary, the high price of advanced medical carts, especially in developing countries, may limit the medical carts market growth over the forecast period. 

Medical Carts Market Segmentation 

The MRFR report provides an inclusive segmental analysis of the global medical carts market report based on end users, material type, product type, and type.  

By product type, the medical carts market is segmented into wall-mounted workstations, medical computing carts, mobile computing carts, medication carts, & others. Of these, mobile computing carts will lead the market over the forecast period.  

By type, the medical carts market is segmented into emergency cart, computer medical cart, anaesthesia cart, procedure cart, and others. Of these, emergency medical carts will dominate the market over the forecast period.  

By material type, the medical carts market is segmented into plastic type, metal type, and others. Of these, the metal segment will have a major share over the forecast period.  

By end user, the medical carts market is segmented into ambulatory surgical centre, hospitals & clinics, and others. Among these, hospitals and clinics will have lions share over the forecast period.  

Medical Carts Market Regional Analysis 

Based on the region, the medical carts market report covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will have the lions share in the market over the forecast period. Increased usage of medical carts for different applications, rising awareness among physicians and patients, and improving research infrastructure are adding market growth in the region.  

The medical carts market in Europe is predicted to hold the second-largest share over the forecast period. Increasing acceptance in developing countries, coupled with growing cases of chronic diseases, is adding market growth in the region.  

The medical carts market in the APAC region is predicted to grow at a high CAGR over the forecast period. Rising patient safety at the community level and hospitals are adding market growth in the region.  

The medical carts market in the MEA is predicted to have the smallest share over the forecast period for the scarcity of well-trained healthcare professionals and low per capita income. 

Medical Carts Market Key Players 

Key players profiled in the global medical carts market report include Ergotron Inc (US), Waterloo Healthcare (US), Jaco Inc (US), Capsa Healthcare (US), The Bergmann Group (US), Midmark Corporation (US), Omnicell Inc. (US), Chang Gung Medical Technology Co. (Taiwan), AFC Industries (US), Harloff Manufacturing Co. (US), Advantech Co. (Taiwan) Ltd, and ITD GmbH (Germany). Key players have adopted strategies such as acquisitions, new product launch, strategic alliance, and mergers to stay ahead in the competition. 

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/medical-carts-market-7436 

Advanced Wound Therapy Devices Market to Reflect Impressive Growth Rate During 2020 - 2023

 

Overview:

The global advanced wound therapy devices market is anticipated to touch a value of USD 2,804.53 million by 2023, asserts Market Research Future (MRFR). The market can showcase 6.70% CAGR from 2018 to 2023 (forecast period).

Increasing incidence of diabetes is the primary driver of the market. Patients with diabetes have a slower healing rate and poor blood circulation which can negatively affect the immunity system. According to the Centers for Disease Control & Prevention (CDC), nearly 30.3 million in the U.S. suffer from diabetes. The advanced wound therapy devices market can expand by capitalizing on this trend and offering precise solutions.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7421

The growing numbers of the geriatric populace will be highly beneficial to the market. This is buttressed by the estimation by the World Health Organization (WHO) which pegs the elderly populace at 1.2 billion by 2025. Furthermore, development of novel products and rapid approval by regulatory bodies is projected to propel the advanced wound therapy devices market. For instance, ConvaTec got approval for its negative pressure wound therapy (NPWT) system by the U.S. FDA in 2018. The hydrofiber gels in the system lock the exudates and bacteria and offer a separate channel for the them to flow away from the wounded region.

Segmentation Analysis:

The advanced wound therapy devices market is segmented by type and end-user.

By type, negative pressure wound therapy systems accounted for 42.9% share in 2017, followed by pressure relief devices (28.2%), hyperbaric oxygen equipment (15.2%), electric stimulation devices (7.9%), and others (5.8%). Negative pressure wound therapy systems can attain revenue close to USD 1,217.41 million by 2023 at 6.91% CAGR over the forecast period. But pressure relief devices are projected to experience the highest CAGR of 7.03% during the assessment period to accrue close to USD 805.35 million by 2023.

Among end-users, hospitals & clinics accounted for 73.7% share in 2017, followed by home care settings (14.5%), and others (11.8%). Hospitals & clinics can register close to 6.95% CAGR during the forecast period to generate close to USD 2,095.66 million by 2023. On the other hand, the home care settings segment is expected to exhibit 6.78% CAGR to touch a size of USD 408.50 million by the end of the forecast period.

Regional Analysis:

Region-wise, the advanced wound therapy devices market is segmented into Europe, Asia Pacific (APAC), Americas, and the Middle East & Africa (MEA).

The Americas are anticipated to reign as the leading region of the market owing to a mix of attractive reimbursement schemes, numerous treatment options, and prevalence of diabetes and chronic wounds. The region can accumulate close to USD 993.07 million by 2023 at 6.11% CAGR over the forecast period.

The European region is touted to register a notable growth rate owing to awareness of chronic wounds, rise in government initiatives, and awareness among healthcare providers. Presence of reputed companies such as Lohmann & Rauscher and technological advances of products can drive the regional advanced wound therapy devices market growth. The region can accrue close to USD 924.85 million by 2023 at 7.02% CAGR over the forecast period.

The APAC region is expected to be extremely lucrative for the advanced wound therapy devices market. This can be credited to high number of burn injury cases and awareness of NPWT devices. It can attain a size of USD 676.27 million by 2023 at 7.16% CAGR over the assessment period.

Competitive Analysis:

Notable player names in the advanced wound therapy devices market are Cardinal Health (U.S.), ConvaTec Inc. (U.K.), Smith & Nephew plc (U.K.), Triage Meditech Pvt. Ltd. (India), Medela AG (Switzerland), Sechrist (U.S.), Mölnlycke Health Care AB (Sweden), B. Braun Melsungen AG (Germany), DeRoyal Industries, Inc. (U.S.), Lohmann & Rauscher GmbH & Co. KG (Germany), Perry Baromedical (U.S.), and KCI Licensing, Inc. (U.S.).

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/advanced-wound-therapy-devices-market-7421

Cell Surface Market to Witness an Outstanding Growth by 2023

 

Market Highlights

The global cell surface markers market is anticipated to hold a market value of USD 498 million in the year 2017 and is expected to grow at a CAGR of 8.4% during the forecast period. Cell surface markers or cell surface antigen work as monograms for identification and classification of cells. The proteins that are expressed on the cell surfaces often conveniently work as markers for specific types of cells.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7410 

Increasing expenditure in the advancement of healthcare technology, advancement in technology, acquisitions by companies and outlook for reduction of costs associated with disease diagnosis are expected to drive the growth in the market over the forecast period. For instance, in April 2014, Beckman Coulter, acquired Xitogen Technologies, a cytometer manufacturer. This acquisition helped Beckman Coulter to broaden its product offerings and enabled business expansion in Asia.  However, complex products and expensive instruments & reagents can restrain the market growth over the assessment period.

Regional Analysis

Geographically, the Americas is expected to dominate the global market owing to the significant amount of research and development activities and well-developed healthcare infrastructure. According to the Organization for Economic Co-operation and Development(OECD), In 2016 united states has spent USD 464,324 million on research and development activities which is 2.7% of total GDP.  Europe is expected to hold the second largest position in the global market owing to the well-developed healthcare infrastructure. Asia-Pacific is expected to be the fastest growing market owing to the growing demand for user friendly targeted therapies. Moreover, the Middle East and Africa region is expected to account for the least market share in the global market.

Segmentation

The global cell surface markers market has been segmented into product, source, cell type and application.

The market, on the basis of product, has been segmented into antibody and PCR array.

The global market, on the basis of source, has been segmented into mice, rat and others.

The global market, on the basis of cell type, has been segmented into T cells, B cells and NK cells. T cells are expected to hold the largest market share owing to high usage of them in research and diagnostics. NK cells are expected to grow at the fastest CAGR owing to increasing application of these types of cell.

The global cell surface markers market, by application, has been segmented into research, clinical and others. Research segment has been further divided into stem cell and immunology. Clinical segment is further divided into oncology and hematology.

Key Players

Some of the prominent players in the global cell surface markers market are Bio-Rad Laboratories, Inc., Abbott, Siemens Healthcare Private Limited, Beckman Coulter, Inc. , F. Hoffmann-La Roche Ltd, NIHON KOHDEN CORPORATION, Thermo Fisher Scientific, BD, Abcam plc., QIAGEN, Danaher, GenScript, Merk KGaA, BioLegend, Inc., Cell Signaling Technology, Inc., Bio-Techne and Others.

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/cell-surface-markers-market-7410

Preclinical Imaging Market Poised to Witness a Significant Growth by 2023

 

Market Highlights

The global preclinical imaging anticipated to have held a market value of USD 2.01 billion in the year 2017 and is expected to grow at a CAGR of 6.3% during the forecast period. Preclinical imaging solutions are used during the preclinical research for visualization of living animals. It is playing important role during drug development process. It is evaluating the effectiveness and safety of new treatments and describing drug distribution patterns before clinical use. preclinical imaging solutions has broad application field such as, neurology; cardiology; inflammation; infectious diseases; cancer research; functional and anatomical neuroimaging, orthopedics; and cardiac imaging.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7365 

Technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches are expected to drive the growth of preclinical imaging market. Many organization and foundation provide the funding support for the preclinical researche activity. The Alzheimer’s Drug Discovery Foundation was providing the funding opportunity for preclinical study up to USD 5 million. Similarly, in 2015 Deutsches Zentrum für Herz-Kreislaufforschung e.V. (DZHK) offered Euro 6 million for the preclinical research projects. This funding supports the market growth.

Regional Analysis

Geographically, the Americas is expected to dominate the global preclinical imaging market owing to the presence of well-established players, technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches. Europe is expected to hold the second largest position in the global preclinical imaging market. Asia-Pacific is expected to be the fastest growing market owing to the increasing funding to support preclinical researches. Furthermore, the Middle East and Africa region is expected to account for the least market share in the global preclinical imaging market.

Segmentation

The global preclinical imaging market has been segmented into modality, reagent, and region.

Based on modality, preclinical imaging market is segmented into optical imaging systems, nuclear imaging systems, micro-MRI, micro-ultrasound, micro-CT, photoacoustic imaging system, and magnetic particle imaging systems. The optical imaging systems segment is expected to account for the largest share segment of the market in 2017.

Based on reagent, preclinical imaging market is segmented into preclinical optical imaging reagents, preclinical nuclear imaging reagents, preclinical MRI contrast agents, preclinical ultrasound contrast agents, and preclinical CT contrast agents. The preclinical optical imaging reagents segment is expected to account for the largest share segment of the market in 2017.

Key Players

Some of the prominent players in the global preclinical imaging market are Bruker Corporation (US), MR Solutions (UK), PerkinElmer Inc. (US), Fujifilm Holdings Corporation (Japan), Milabs B.V. (The Netherlands), Mediso Ltd. (Hungary), LI-COR, Inc. (US), Miltenyi Biotec GmbH (Germany), Aspect Imaging (Israel), and Trifoil Imaging (US).

Browse Complete Report @ https://www.marketresearchfuture.com/reports/preclinical-imaging-market-7365 

Veterinary Laboratory Testing Market Poised to Witness a Significant Growth by 2023

 

Market Highlights

The global veterinary laboratory testing market is expected to grow at a CAGR of 10.1% during the forecast period.

Increasing expenditure on pet insurance, growth in the number of veterinary practitioners, advancements in healthcare facilities, and favorable funding policies are expected to drive the market growth over the forecast period.

However, high cost of veterinary testing and complications associated with the tests can restrain the market growth over the assessment period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7326   

Regional Analysis

Geographically, the Americas is anticipated to dominate the global veterinary laboratory testing market owing to the increasing cases of animal disease and technological advancements in veterinary diagnostics. For instance, in 2016, IDEXX Laboratories, Inc. launched the Rapid Visual Pregnancy Test for cattle. With the new test, veterinarians can more quickly identify open cows using whole blood samples collected before the farm visit. Europe is expected to hold the second largest position in the global veterinary laboratory testing market. The market growth in this region is attributed to the rising expenditure on pet insurance. The Veterinary Laboratory Testing Market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the awareness regarding use of sterile consumables for lab testing and rising healthcare spending. The Middle East & Africa contributes least in the global market for veterinary laboratory testing.\

Segmentation

The global veterinary laboratory testing market has been segmented into animal type, technology, product, and end user.

The market, on the basis of animal type, has been segmented into companion animal and livestock animal. The companion animal segment is further classified as dogs, cats, horses and others. The livestock animal segment is further classified as cattle, pigs, poultry and others.

The market, by technology, has been segmented into clinical biochemistry, immunodiagnostics, hematology, molecular diagnostics, urinalysis, and others.

The clinical biochemistry segment is further classified as clinical chemistry analysis, glucose monitoring, and blood gas & electrolyte analysis. The clinical chemistry analysis segment includes clinical chemistry reagent clips and cartridges and clinical chemistry analyzers. The glucose monitoring segment includes blood glucose strips, glucose monitors and urine glucose strips. The blood gas & electrolyte analysis segment includes blood gas and electrolyte reagent clips and cartridges and blood gas & electrolyte analyzers.

The immunodiagnostics segment is further classified as ELISA tests, lateral flow assays, allergen-specific immunodiagnostic tests, immunoassay analyzers, and others. The lateral flow assays segment includes lateral flow rapid tests, and lateral flow strip readers.

The hematology segment is further classified as hematology cartridges, and hematology analyzers.

The molecular diagnostics segment is further classified as polymerase chain reaction (PCR) tests, microarrays, and others.

The urinalysis segment is further classified as urinalysis clips & cartridges/panels, urine analyzers, and urine test strips.

The market, by product, has been segmented into consumables and instruments.

The market, by end user, has been segmented into veterinary hospitals & clinics, in-house testing, research institutes, diagnostic laboratories, and others. The veterinary hospitals & clinics segment held the largest segment of the market in 2017. This can be attributed to the increasing incidence of zoonotic diseases. On the other hand, the academic institutes segment is estimated to be the fastest growing segment.

Key Players

Some of the prominent players in the global veterinary laboratory testing market are Abaxis, Inc., BIOCHECK Inc., Biomérieux SA, Henry Schein, Inc., Heska Corporation, Idexx Laboratories, Idvet, Neogen Corporation, Pfizer, Qiagen N.V., Randox Laboratories, Ltd., Thermo Fisher Scientific, VCA Inc., Virbac, Zoetis, Inc. and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/veterinary-laboratory-testing-market-7326